Author:
Kalinowski Danuta S.,Stefani Christian,Toyokuni Shinya,Ganz Tomas,Anderson Gregory J.,Subramaniam Nathan V.,Trinder Debbie,Olynyk John K.,Chua Anita,Jansson Patric J.,Sahni Sumit,Lane Darius J.R.,Merlot Angelica M.,Kovacevic Zaklina,Huang Michael L.H.,Lee C. Soon,Richardson Des R.
Funder
Cancer Institute New South Wales (CINSW)
Prostate Cancer Foundation of Australia (P.J.J.)
National Health and Medical Research Council of Australia (NHMRC)
NHMRC
Sydney Medical School Foundation
AMP Foundation
Sydney Medical School
CINSW
NHMRC Peter Doherty Early Career Fellowship
NHMRC Practitioner Fellowship
NHMRC Senior Research Fellowship
NHMRC Project Grant
Subject
Cell Biology,Molecular Biology
Reference331 articles.
1. Iron chelators in cancer chemotherapy;Buss;Curr. Top. Med. Chem.,2004
2. The evolution of iron chelators for the treatment of iron overload disease and cancer;Kalinowski;Pharmacol. Rev.,2005
3. Targeting copper in cancer therapy: ‘Copper that Cancer’;Denoyer;Metallomics,2015
4. Essentiality, toxicology and chelation therapy of zinc and copper;Cai;Curr. Med. Chem.,2005
5. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators;Nyholm;J. Biol. Chem.,1993
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献